Abstract
Objective
Sexual activity (SA) and functioning (SF) are important factors influencing quality of life (QoL). Anticancer treatment can cause or promote sexual dysfunctions. In this study we analyzed the SA, SF and QoL in patients after completion of treatment for breast cancer (BC) and ovarian cancer (OC).
Methods
In this retrospective multicenter study 396 BC patients and 93 OC patients aged between 18 and 70 years were surveyed at least 24 months after cancer diagnosis and compared to 60 healthy women. Data were collected through validated questionnaires (Sexual Activity Questionnaire, Female Sexual Function Index-d, EORTC Quality of Life Questionnaire-C30).
Results
45.9% of BC patients and 56.5% of OC patients reported SA. SF and well-being of sexually active BC patients were not influenced by the type and radicality of surgery or the administration of chemotherapy. Patients who received antihormonal therapy at the time of evaluation showed a lower frequency of SA (p = 0.007), less satisfaction (p = 0.003) and more discomfort during SA (p = < 0.001) compared to healthy controls but no differences in experiencing orgasms, health status, QoL and global health status. In contrast, BC patients without antihormonal therapy showed only a higher discomfort score (p = 0.028) than healthy controls and estimated their health status and QoL significantly better than patients who received antihormonal therapy (p = 0006). In general, SA was associated with a better health status (p = 0.007), a better QoL (p = 0.004) and a better global health status (p = 0.004) in BC patients. Sexually active OC patients showed no significant differences in SF, QoL and health status compared to healthy controls.
Conclusions
Compared to healthy controls BC patients showed limitations in SF with a lower SA rate and more discomfort. Antihormonal therapy was an important factor influencing SF and well-being. Breast and OC survivors reported good physical and psychical health without differences in QoL and health status compared to controls. This might be explained by a change of perspective on life difficulties and altered priorities through a life threatening disease.
Similar content being viewed by others
References
Chopra I, Kamal KM (2012) A systematic review of quality of life instruments in long-term breast cancer survivors. Health Qual Life Outcomes 10:14
Hasenburg A, Schröck R, Schmalfeldt B, Ortmann A (2008) Nachsorge und rehabilitation nach therapie eines ovarialkarzinoms. Onkologe 14:1172–1178
Thors CL, Broeckel JA, Jacobsen PB (2001) Sexual functioning in breast cancer survivors. Cancer Control 8(5):442–448
Audette C, Waterman J (2010) The sexual health of women after gynecologic malignancy. J Midwifery Womens Health 55(4):357–362
Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2):501–514
Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21(22):4184–4193
Al-Ghazal SK, Fallowfield L, Blamey RW (2000) Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 36(15):1938–1943
Ohsumi S, Shimozuma K, Kuroi K, Ono M, Imai H (2007) Quality of life of breast cancer patients and types of surgery for breast cancer—current status and unresolved issues. Breast Cancer 14(1):66–73
Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR (2006) Body image and sexual problems in young women with breast cancer. Psychooncology 15(7):579–594
Cavalheiro JA, da Bittelbrunn A, Menke CH, Biazús JV, Xavier NL, Cericatto R (2012) Sexual function and chemotherapy in postmenopausal women with breast cancer. BMC Womens Health 12:28
Schover LR, Yetman RJ, Tuason LJ, Meisler E, Esselstyn CB, Hermann RE (1995) Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 75(1):54–64
Aerts L, Christiaens MR, Enzlin P, Neven P, Amant F (2014) Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast 23(5):629–636
Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB (2017) Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35(22):2499–2506
Cortés-Flores AO, Vargas-Meza A, Morgan-Villela G, Jiménez-Tornero J, del Valle CJZ-F, Solano-Genesta M (2017) Sexuality among women treated for breast cancer: a survey of three surgical procedures. Aesthetic Plast Surg 41(6):1275–1279
Kim SI, Lee Y, Lim MC, Joo J, Park K, Lee DO (2015) Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women. J Gynecol Oncol 26(2):148–154
Li C-C, Rew L, Chen L (2014) Factors affecting sexual function: a comparison between women with gynecological or rectal cancer and healthy controls. Nurs Health Sci 17(1):105–111
Stabile C, Goldfarb S, Baser RE, Goldfrank DJ, Abu-Rustum NR, Barakat RR (2017) Sexual health needs and educational intervention preferences for women with cancer. Breast Cancer Res Treat 165(1):77–84
Thirlaway K, Fallowfield L, Cuzick J (1995) The sexual activity questionnaire: a measure of women’s sexual functioning. Qual Life Res 5(1):81–90
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
Oberguggenberger A, Martini C, Huber N, Fallowfield L, Hubalek M, Daniaux M (2017) Self-reported sexual health: breast cancer survivors compared to women from the general population—an observational study. BMC Cancer 17(1):599
Candy B, Jones L, Vickerstaff V, Tookman A, King M (2016) Interventions for sexual dysfunction following treatments for cancer in women. In: The Cochrane Library [Internet]. John Wiley & Sons, Ltd. Verfügbar unter. http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD005540.pub3/full. zitiert 20. März 2018
Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE (2002) Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75(3):241–248
Panjari M, Bell RJ, Davis SR (2011) Sexual function after breast cancer. J Sex Med 8(1):294–302
Avis NE, Johnson A, Canzona MR, Levine BJ (2018) Sexual functioning among early post-treatment breast cancer survivors. Support Care Cancer 26(8):2605–2613
Mortimer JE, Boucher L, Baty J, Knapp DL, Ryan E, Rowland JH (1999) Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol 17(5):1488
Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B (2016) Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Clin Oncol [Internet]. Verfügbar unter. http://ascopubs.org/doi/abs/10.1200/JCO.1999.17.9.2659?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed. zitiert 29 März 2018
Bradford A (2013) Sexual outcomes of aromatase inhibitor therapy in women with breast cancer: time for intervention. Menopause 20(2):128–129
Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20(2):162–168
Taylor CLC, Basen-Engquist K, Shinn EH, Bodurka DC (2004) Predictors of sexual functioning in ovarian cancer patients. J Clin 22(5):881–889
Zhou Y, Irwin ML, Ferrucci LM, McCorkle R, Ercolano EA, Li F (2016) Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society’s Study of Cancer Survivors—I. Gynecol Oncol 141(3):543–549
Ersek M, Ferrell BR, Dow KH, Melancon CH (1997) Quality of life in women with ovarian cancer. West J Nurs Res 19(3):334–350
Author information
Authors and Affiliations
Contributions
SM protocol/project development, data collection, data analysis, manuscript writing/editing. SI data collection, data analysis. DG data collection, manuscript editing. LS data collection. SM Protocol/project development, data collection. MB data collection, manuscript writing/editing. LW Protocol/project development, data collection, manuscript editing. PJV data collection. GG data collection. AH Protocol/project development, data collection, manuscript writing/editing
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no potential conlicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mayer, S., Iborra, S., Grimm, D. et al. Sexual activity and quality of life in patients after treatment for breast and ovarian cancer. Arch Gynecol Obstet 299, 191–201 (2019). https://doi.org/10.1007/s00404-018-4922-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-018-4922-2